Inactive

Amendment 0001. The purpose of this amendment is to specify the timeframe for questions generated in response to the combined synopsis solicitation 36C25220Q0122. All questions are due by 05 June 2020... Amendment 0001. The purpose of this amendment is to specify the timeframe for questions generated in response to the combined synopsis solicitation 36C25220Q0122. All questions are due by 05 June 2020 at 1600 local time. All questions received will be addressed and posted as amendment to the solicitation at a later date. B. All questions shall be submitted in writing to the contracting officer at: David.Picchi@va.gov No other forms of questions will be accepted. Amendment 0002. Updated submission date for questions due to the contracting officer now due by 05 June 2020. Updated attachments providing LIS data for all sites. Posted 28 May 2020. See attachments for additional information. Amendment 0003. The purpose of this amendment is to provide answers to questions received in response to the combined synopsis/soliciation 36C25220Q0122. Answers are posted as an attachment along with an updated "Attachment A-E" in response. Proposal due date time is 22 June 2020 at 1600 CST.

Inactive

SOURCES SOUGHT SYNOPSIS The Department of Veterans Affairs is issuing this sources sought synopsis as a means of conducting market research to identify parties having an interest in, and the resources... SOURCES SOUGHT SYNOPSIS The Department of Veterans Affairs is issuing this sources sought synopsis as a means of conducting market research to identify parties having an interest in, and the resources to support, a requirement for Chemistry testing on a cost-per-reportable result basis for approximately 8 main hospitals/medical centers and multiple Community Based Outreach Centers (CBOCs) within VISN 12. The results of this market research will contribute to determining the method of procurement. The applicable North American Industry Classification System (NAICS) code assigned to this procurement is 334516 Analytical Laboratory Instrument Manufacturing. THERE IS NO SOLICITATION AT THIS TIME. This request for capability information does not constitute a request for proposals/quotes; submission of any information in response to this market survey is purely voluntary; the government assumes no financial responsibility for any costs incurred. If your organization has the potential capacity to perform these contract services, please provide the following information: 1) Organization name, address, email address, Web site address, telephone number, and size and type of ownership for the organization; and 2) Tailored capability statements addressing the particulars of this effort, with appropriate documentation supporting claims of organizational and staff capability. The government will evaluate market information to ascertain potential market capacity to provide services consistent in scope and scale with those described in this notice and otherwise anticipated. BASED ON THE RESPONSES TO THIS SOURCES SOUGHT NOTICE/MARKET RESEARCH, THIS REQUIREMENT MAY BE SET-ASIDE FOR SMALL BUSINESSES OR PROCURED THROUGH FULL AND OPEN COMPETITION. Telephone inquiries will not be accepted or acknowledged, and no feedback or evaluations will be provided to companies regarding their submissions. Submission Instructions: Interested parties who consider themselves qualified to perform the above-listed services are invited to submit a response to this Sources Sought Notice by 12:00 PM Central, November 19, 2019. All responses under this Sources Sought Notice must be emailed to jessica.rasmussen3@va.gov. PERIOD OF PERFORMANCE The estimated period of performance would be a base period with four option years. SCOPE Contractor would be required to provide instruments, including backup instrumentation, as required, middleware, reagents, ancillary supplies, controls, service/maintenance captured on a cost per reportable result basis. Contractor would be required to adhere to all applicable clinical standards. The instrument shall have random access capability (if discrete testing is required) and be able to simultaneously perform a complete profile and meet the performance characteristics for accuracy and precision as defined by the 1988 Clinical Laboratory Improvement Act (CLIA) and the Clinical and Laboratory Standards Institute (CLSI). Contractor would be required to provide emergency service for outages. Contractor will be required to provide characterization of hazardous waste. Below is the list of possible analytes: Acetaminophen Hepatitis B Core Antibody, total Urine Protein & CSF Protein ACTH Hepatitis B Surface Antibody Valproic Acid Albumin Hepatitis B Surface Antigen Vancomycin Alcohol Hepatitis A, IgM Vitamin B12 Alkaline Phosphatase Hepatitis C Antibody Vitamin D Alpha Fetoprotein HIV Antibody Myoglobin ALT Homocysteine Ammonia hsCRP or cardio CRP Amphetamine, urine IgA Amylase IgE Anti-Thyroid Peroxidase IgG Antitrypsin, alpha 1 IgM AST Insulin Autoantibody Thyroglobulin Intact PTH Barbiturates, urine Iron Benzodiapines, urine Lactic Acid BHCG LDH Blood Urea Nitrogen Lidocaine BNP Lipase CA 19-9 Lithium Calcium Luteinizing Hormone Carbamazepine Magnesium CEA Mass CKMB Ceruloplasmin Methadone, urine Chloride Microalbumin Cholesterol Micrglobulin, beta-2 CO2 Opiates, urine Cocaine, urine PCP, urine Complement C3 Phenobarbital Complement C4 Phosphorus Cortisol Potassium C-Peptide Pre-Albumin Creatine Kinase Prolactin Creatine Enzymatic PSA, Free CRP PSA, Total Cyclosporine Rheumatoid Factor DHEA-S Rubella, IgG Digoxin Salicylate Dilantin Sex Hormone Binding Globulin Direct Bilirubin Sodium Direct LDL Specialty Albumin Estradiol Syphilis Ferritin Tacrolimus Folate, Serum Testosterone Follicle Stimulating Hormone THC, urine Free T3 Theophylline FT4 TIBC Gentamicin Tobramycin GGT Total Bilirubin Glucose Total Protein Haptoglobin Triglycerides HDL Troponin-I Hepatitis A, Total TSH Hepatitis B Core Antibody, IgM Uric Acid